NASDAQ: CALT - Calliditas Therapeutics AB (publ)

Yield per half year: 0%
Dividend yield: 0.00%
Sector: Healthcare

Share chart Calliditas Therapeutics AB (publ)

Extended chart Simple chart
Financial Markets by TradingView

About Calliditas Therapeutics AB (publ)

Calliditas Therapeutics AB (publ), биофармацевтическая компания, работающая на клинической стадии, сосредоточилась на выявлении, разработке и коммерциализации фармацевтических продуктов для лечения сиротских симптомов с первоначальным акцентом на заболеваниях почек и печени. Основным кандидатом на продукцию компании является Нефекон, пероральный препарат будесонида, который является иммунодепрессантом для лечения аутоиммунной почечной нефропатии IgA. Calliditas Therapeutics AB (publ) была основана в 2004 году со штаб-квартирой в Стокгольме, Швеция.

Add to compare list
Add to watchlist
Add to portfolio
Add to notification price

IPO date 2020-06-05
ISIN US13124Q1067
Industry Biotechnology
Sector Health Care
Валюта usd
Валюта отчета sek
Сайт https://www.calliditas.se
Цена ао 40
Change price per year: +86.16% (21.4867)
Change price per 3 year: +102.33% (19.77)
All parameters

Underestimation

Title Value Grade
P/S 12.89 1
P/BV 46.46 1
P/E 0 0
EV/EBITDA -42.31 0
Total: 3

Efficiency

Title Value Grade
ROA, % -24.53 0
ROE, % -139.24 0
Total: 0

Dividends

Title Value Grade
Div yield, % 0 0
DSI 0 0
Total: 0

Debt

Title Value Grade
Debt/EBITDA -2.59 10
Total: 8

Growth impulse

Title Value Grade
Yield Revenue, % 552.98 10
Yield Ebitda, % 1363.6 10
Yield EPS, % 5543.8 10
Total: 10
More

Institutions Volume Share, %
BVF Inc. 750000 2.52
Deutsche Bank Aktiengesellschaft 50550 0.17
Ironwood Investment Management, LLC 25435 0.09
Susquehanna International Group, LLP 9412 0.03
Wells Fargo & Company 1500 0.01
Osaic Holdings Inc 1172 0
Optiver Holding B.V. 980 0
UBS Group AG 952 0
Planning Capital Management Corp 877 0
Citadel Advisors Llc 827 0



Head Job title Payment Year of birth
Ms. Renee Aguiar-Lucander Chief Executive Officer 8.99M 1962 (63 years)
Mr. Fredrik Johansson Chief Financial Officer N/A 1977 (48 years)
Ms. Sandra Frithiof Vice President of Human Resources N/A 1975 (50 years)
Ms. Ann-Kristin Myde BSc Head of Clinical Development & VP of Project Management N/A 1955 (70 years)
Dr. Richard S. Philipson M.D. Chief Medical Officer N/A 1964 (61 year)
Ms. Teona Johnson Head of US Marketing N/A
Mr. Brian Gorman Group General Counsel N/A 1976 (49 years)
Mr. David Ferraro Head of US Sales N/A
Lars Stubberud Vice President of Technical Operations 1964 (61 year)
Ms. Asa Hillsten Head of IR & Sustainability 1975 (50 years)

Address: Sweden, Stockholm, Kungsbron 1 D5 - open in Google maps, open in Yandex maps
Website: https://www.calliditas.se